Blood test for early detection of pancreatic cancer headed to clinic

A newly identified biomarker panel could pave the way to earlier detection and better treatment for pancreatic cancer. Currently over 53,000 people in the United States are diagnosed with pancreatic cancer — the fourth leading cause of cancer death — every year. The blood biomarkers correctly detected pancreatic cancer in blood samples from patients at different stages of their disease. (Mehr in: Cancer News — ScienceDaily)